In8Bio (INAB) Capital Leases (2021 - 2025)
In8Bio's Capital Leases was $64,000 in Q3 2025, down 84.0% from $399,000 a year earlier and down 49.2% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Capital Leases (2021 - 2025) Analysis & Trends
At the end of FY2024, Capital Leases at In8Bio came in at $295,000, down 43.8% from FY2023.
- Capital Leases shows a three-year compound annual growth rate of 3.1% (FY2021 to FY2024).
- In earlier years, Capital Leases was $525,000 in FY2023 (-35.3%), $811,000 in FY2022 (+201.5%) and $269,000 in FY2021.
- The Q3 2025 figure marks the lowest quarterly Capital Leases in data going back to Q2 2021.
- Compared with a year earlier, Capital Leases has declined for eight straight quarters, with an average decline of 51.7% over the last eight quarters.
- The best year-over-year quarter for Capital Leases over five years was Q3 2023 (growth of 937.3%); the worst was Q3 2025 (a decline of 84.0%).
- Per Business Quant data, INAB's Capital Leases in the three quarters before Q3 2025 was $126,000 (Q2 2025), $189,000 (Q1 2025) and $295,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | In8Bio | 20.44 Mn | -57.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 126,000.00 |
| Mar 31, 2025 | 189,000.00 |
| Dec 31, 2024 | 295,000.00 |
| Sep 30, 2024 | 399,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Mar 31, 2024 | 351,000.00 |
| Dec 31, 2023 | 525,000.00 |
| Sep 30, 2023 | 695,000.00 |
| Jun 30, 2023 | 861,000.00 |
| Mar 31, 2023 | 664,000.00 |
| Dec 31, 2022 | 811,000.00 |
| Sep 30, 2022 | 67,000.00 |
| Jun 30, 2022 | 132,000.00 |
| Mar 31, 2022 | 201,000.00 |
| Dec 31, 2021 | 269,000.00 |
| Sep 30, 2021 | 343,000.00 |
| Jun 30, 2021 | 432,000.00 |
API Access
In8Bio Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();